microdosing glp 1 GLP-1 is popular, but there's little evidence it works GLP-1 Microdosing | Chicago Concierge

The HARMONY trial studied T2DM patients, 40 years and older, with established cardiovascular disease and reported that albiglutide reduced the primary composite outcome

Novo Nordisk) in 2017

Synedica Retatrutide An informational overview of retatrutide, an investigational compound studied for its interaction with GLP-1, GIP, and glucagon receptor pathways

Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials

Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1

( 10.1001/jama.2022.0078) [DOI] [PMC free article] [PubMed] [Google Scholar] Darpo B, Sager P, MacConell L, Cirincione B, Mitchell M, Han J, Huang W, Malloy J, Schulteis C, Shen L, et al